News
-
-
-
-
-
-
PRESS RELEASE
MedMira Receives Canadian Patent for its Unique Quantitative Diagnostic System
MedMira Inc. announces the receipt of a Canadian patent for a new quantitative test system using Rapid Vertical Flow Technology, enhancing its diagnostic tests. The system offers qualitative and quantitative results in minutes, revolutionizing disease screening and monitoring -
PRESS RELEASE
CORRECTION BY SOURCE: Corporate Update on Clinical Evaluation of MedMira's Products
MedMira Inc. provides an update on its submission to Health Canada, extending its intended use to address the increasing need in maternity screening. The company's syphilis component demonstrates promising results, with plans to submit a comprehensive dataset for additional claims approval by February 2024 -
PRESS RELEASE
Corporate Update on Clinical Evaluation of MedMira’s Products
MedMira Inc. provides update on Health Canada review process for maternity screening, highlighting increasing need due to rising syphilis infection rates. Company's syphilis test performance shows promising results for infectious case detection and maternity screening -
PRESS RELEASE
MedMira Reports First Quarter Results FY2024
MedMira Inc. (TSXV:MIR) has reported its financial results for the quarter ended October 31, 2023. The company achieved significant milestones during this period, including receiving US FDA 510(k) clearance for the HIV-2 claim on its Reveal® G4 Rapid HIV 1/2 antibody test. This approval positions MedMira as a key player in the HIV testing market and allows the company to expand its market share and revenue in the United States. -
![Accesswire](/assets/images/accesswire-inline.png)
-
Eagle Plains Announces Conditional Approval of Warrant Expiry Extension
-
Goldflare Announces Changes in Leadership
-
Gina Corena & Associates Participates in 2024 Nevada Justice Association Annual Summer Gala This Weekend
-
Canada Jetlines Announces Loan
-
Pixalate Introduces EMEA Connected TV (CTV) Supply-Side Platform (SSP) Market Share Rankings: Magnite No. 1 With 43% Market Share in Q1 2024
![EQS Group](/assets/images/eqs-group.png)
-
EQS-Adhoc: VOLKSWAGEN AKTIENGESELLSCHAFT: Volkswagen AG resolves on investment by Volkswagen of initially 1 billion USD in Rivian Automotive, Inc., and intends to establish a joint venture
-
CompuGroup Medical strengthens market position in Northern Europe with the acquisition of Norwegian Pridok
-
EQS-Adhoc: CompuGroup Medical SE & Co. KGaA: CompuGroup Medical acquires Pridok AS
-
Molten Ventures Plc: HOL-Holding(s) in Company
-
Annual General Meeting 2024 of Meyer Burger approves all motions
![Les Echos](/assets/images/les-echos.png)
-
RESULTS OF THE COMBINED GENERAL MEETING ON JUNE 24, 2024
-
Schneider Electric announces the reference share price and the initial conversion/exchange ratio of its new bonds convertible into new shares and/or exchangeable for existing shares (OCEANEs) due 2031 and the results of the repurchase of the OCEANEs
-
FREY signs new financing for €400m
-
Schneider Electric announces the success of its offering of bonds convertible into new shares and/or exchangeable for existing shares (OCEANEs) due 2031 for a nominal amount of €750 million
-
Cie du Bois Sauvage: Buy back of own shares – week from 17/06/2024 to 21/06/2024